SynthesisFrontiers in cardiovascular medicine2022

SGLT2 Inhibitors in Diabetic Patients With Cardiovascular Disease or at High Cardiovascular Risk: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Zinan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.